IMUNON
Live / Registered — Registered (as of 11 Aug 2026)
What this means for you
Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 97036154
- Registration number
- 8392766
- Mark type
- Word mark
- Filed
- 20 Sept 2021
- Published for opposition
- 16 May 2023
- Registered
- 11 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals for the treatment of cancer
- Class 042 — Scientific and technological services: Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; biological analysis; providing scientific research information in the field of clinical trials; Development of pharmaceutical preparations for treating cancer; scientific and technological research in the fields of immunotherapy and oncology
Owner
- IMUNON, INC., LAWRENCEVILLE, NJ, US
- IMUNON, INC., LAWRENCEVILLE, NJ, US
- Celsion Corporation, Lawrenceville, NJ, US
- Celsion Corporation, Lawrenceville, NJ, US
Prosecution history
- 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jul 2026 — USE AMENDMENT FILED
- 14 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 13 Jul 2026 — SOU EXTENSION 5 GRANTED
- 12 Jan 2026 — SOU EXTENSION 5 FILED
- 12 Jan 2026 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 25 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jun 2026 — ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
- 04 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP